Tag Archives: Pharma

Pfizer’s real strategy is (mostly) tax-minimization

   Many observers were initially left scratching their heads over Pfizer’s pursuit of AstraZeneca, a company that has had major pipeline troubles of its own.  As more information has come out, Pfizer’s strategy is beginning to make sense.  They aren’t pursuing an old-style mega … Continue reading

Posted in Pharmaceutical Industry | Tagged , , , , | 1 Comment

Fixing Big Pharma Research: Expected cost savings have to be recoverable

All too often the cost savings from efficiency improvements of various kinds are dramatically over estimated, especially when large numbers of small improvements are aggregated. Companies of all kinds (not just Pharma) often justify investments in new equipment or software … Continue reading

Posted in Fixing Big Pharma Research, Management | Tagged , , , , , | Leave a comment

Fixing Big Pharma Research: The costs of delays need to be properly valued

For the Pharmaceutical industry, the foregone revenue created by delays in bringing a drug to market can be surprisingly high — from $50,000 to $2,000,000 per day, depending on the phase of the pipeline. Such costs are often under appreciated. … Continue reading

Posted in Management, Research | Tagged , , , | Leave a comment